URGN Competitors & Alternatives
Compare UroGen Pharma Ltd with similar stocks in the same industry
Biotechnology
URGN
Main Stock$26.60
Tradestie Score
55
Market Cap
$824.20M
Revenue Growth
1.5%
Analyst Upside
+38.6%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$18.34
|
$1.35B | - | 52 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$37.00
|
$1.32B | - | 55 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$5.89
|
$1.29B | 85.7 | 58 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.46
|
$1.29B | - | 56 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.42
|
$1.29B | - | 49 | Compare |
|
ZYME
Zymeworks Inc.
|
$24.35
|
$1.28B | - | 55 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.72
|
$1.27B | - | 63 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$36.70
|
$1.26B | - | 54 | Compare |
|
MPLT
MPLT
|
$28.34
|
$1.24B | - | 56 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
More URGN Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry